Biotech

All Articles

ArsenalBio increases $325M, pivots far from past lead asset

.Toolbox Biosciences is carrying on up. The cell treatment company has actually added on $325 thousa...

Lilly- supported fat burning biotech documents IPO

.After elevating $170 thousand back in February, metabolic disease-focused BioAge Labs has actually ...

Aelis' marijuana usage medicine fails phase 2b, steering Indivior to reconsider $100M option

.Aelis Farma's hopes of securing a fast, favorable choice on a $100 thousand option settlement have ...

ProKidney stops stage 3 test certainly not required for tissue therapy approval

.ProKidney has actually stopped among a set of stage 3 trials for its tissue therapy for kidney heal...

Vaxcyte surges on 'impressive' 31-valent PCV gain against Pfizer

.Vaxcyte unveiled what professionals named "sensational" stage 1/2 records for its own 31-valent pne...

Recursion's mind disease trial shows little proof of efficacy

.Recursion has stumbled by means of an early test of its tech-enabled strategy to medicine explorati...

Acepodia, Pfizer click with each other for chemistry-based cell treatment

.Contact it an instance of really good chemistry: Acepodia, a biotech based upon Nobel Prize-winning...

Praxis epilepsy medication minimizes seizures in period 2 hearing

.Praxis Precision Medicines has racked up another midphase win in epilepsy this year, with its sodiu...

Three execs surrender as Dyne articles mixed information for DMD prospect

.After running away a clinical grip a number of years back, Dyne Rehab has disclosed brand-new perio...

Arrowhead fires off period 3 data in unusual metabolic condition in front of market encounter Ionis

.Arrowhead Pharmaceuticals has revealed its hand in advance of a possible showdown with Ionis, publi...